Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 42fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 32Mycophenolic Acid 26Whole-Body Irradiation 23Cyclosporine 23Busulfan 23Radiotherapy 19Filgrastim 19Antilymphocyte Serum 19Tacrolimus 16Melphalan 16Methotrexate 12Methylprednisolone 10Cord Blood Stem Cell Transplantation 10Etoposide 8Thiotepa 6sargramostim 5fludarabine 5Therapeutics 5aldesleukin 4Sirolimus 4Cytarabine 4Polymerase Chain Reaction 3Paclitaxel 3Granulocyte Colony-Stimulating Factor 3Carmustine 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Amyloid × Sarcoma × Clear all
NCT05169151 2023-04-24

Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study

M.D. Anderson Cancer Center

Withdrawn
CNSLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡